Complications in thyroid resurgery: a single institutional experience on 233 patients from a whole series of 4,752 homogeneously treated patients

Endocrine - Tập 47 - Trang 100-106 - 2014
M. R. Pelizzo1, M. Variolo1, C. Bernardi1, M. Izuzquiza1, A. Piotto1, G. Grassetto2, P. M. Colletti3, I. Merante Boschin1, D. Rubello2,4
1Surgical Clinic II, Department of Surgical, Oncological and Gastroenterological Sciences, University of Padova, Padua, Italy
2Nuclear Medicine Department, Santa Maria della Misericordia Hospital, Rovigo, Italy
3Radiology Department, University of Southern California, Los Angeles, USA
4Department of Imaging, Nuclear Medicine, Radiology, NeuroRadiology, Medical Physics, Clinical Laboratory, Biotechnology Laboratory, Microbiology, Pathology, Padova University, Padua, Italy

Tóm tắt

The aim of this study was to examine a homogeneous, consecutive recent series of patients who underwent reoperation on the thyroid bed to assess the incidence of the complications commonly correlated with resurgery. We reviewed clinical charts of 233 patients who underwent resurgery taken from a total of 4,752 patients previously operated on for benign and malignant thyroid diseases from 2006 to 2010 by the same surgical team. We evaluated the incidence of postoperative hemorrhage, hypoparathyroidism, and recurrent laryngeal nerve (RLN) palsy. Analyses were done separately in relation to the type of the type of resurgery adopted: (A) monolateral completion; (B) bilateral completion, after monolateral (B1) or bilateral prior surgery (B2); and (C) lymph node dissection. We also separately analyzed patients according to their final histological diagnosis of benign or malignant disease. Regarding hemorrhage, 6/233 patients (2.5 %) underwent surgical revision of the thyroid within 12 h for postoperative hemorrhage. They included 2 (1.5 %) of the 129 monolateral reoperations (A), 3 (4 %) of the 74 bilateral reoperations (B), and 1 (3.3 %) of the 30 central dissections for nodal relapse (C). Transient and definitive postoperative hypoparathyroidism was recorded in 78 (36.4 %) and 7 (3.3 %) of the 214 eligible patients. Transient RLN palsy occurred in 21 RLNs at risk (7 %) and definitive RLN palsy in 5 (1.7 %). Elective total thyroidectomy cannot always be supported as an effective policy for preventing recurrences in patients with a single, benign node: lobectomy, preferably with extemporaneous histological examination, unquestionably represents the best minimal approach to thyroid resection.

Tài liệu tham khảo

M.R. Pelizzo, Thyroid surgery. G. Chir. 32, 453–459 (2011) C.A. Seiler, S.A. Vorburger, U. Burgi, D. Candinas, S.W. Shmid, Extended resection for thyroid disease has less operative morbidity than limited resection. World J. Surg. 31, 1005–1013 (2007) P.G. Calò, M. Tuveri, G. Pisano, A. Tatti, F. Medas, M. Donati, A. Nicolosi, Il gozzo recidivo Nostra esperienza. Chir. Ital. 61, 545–549 (2009) S. Calabro, L.J. Auguste, J.N. Attie, Morbidity of completion thyroidectomy for initially misdiagnosed thyroid carcinoma. Head Neck Surg. 10, 235–238 (1988) D.J. Terris, S. Khichi, S.K. Anderson, M.W. Seybt, Reoperative thyroidectomy for benign thyroid disease. Head Neck (2010). doi:10.1002/hed.21196 M.K. Kim, S.H. Mandel, Z. Baloch, V.A. LiVolsi, J.E. Langer, L. Di Donato, S. Fish, R.S. Weber, Morbidity following central compartment reoperation for recurrent or persistent thyroid cancer. Arch. Otolaryngol. Head Neck Surg 130, 1214–1216 (2004) J.L. Roh, J.M. Kim, C.I. Park, Central compartment reoperation for recurrent/persistent differentiated thyroid cancer: patterns of recurrence, morbidity, and prediction of postoperative hypocalcemia. Ann. Surg. Oncol. 18, 1312–1318 (2011) J.L. Pasieka, N.W. Thompson, M.K. McLeod, R.E. Burney, M. Macha, The incidence of bilateral well-differentiated thyroid cancer found at completion thyroidectomy. World J. Surg. 16, 711–717 (1992) F. Manegaux, G. Turpin, M. Dahman, L. Leenhardt, R. Chadarevlan, A. Aurengo, L. Du Pasquier, J.P. Chigot, Secondary thyroidectomy in patients with prior thyroid surgery for benign disease: a study of 203 cases. Surgery 125, 479–483 (1999) D. Pironi, A. Panarese, S. Candioli, A. Manigrasso, G. La Gioia, A.M. Romani, S. Arcieri, R. Mele, A. Filippini, Reoperative thyroid surgery: personal experience and review of the literature. G. Chir. 29, 407–412 (2008) T.C. Chao, L.B. Seng, J.D. Lin, M.F. Chen, Reoperative thyroid surgery. World J. Surg. 21, 644–647 (1997) J.H. Lefevre, C. Tresallet, L. Leenhardt, C. Jublanc, J.P. Chigot, F. Menegaux, Reoperative surgery for thyroid disease. Langenbecks. Arch. Surg. 392, 685–691 (2007) J.E. Gosnell, O.H. Clark, Surgical approaches to thyroid tumors. Endocrinol. Metab. Clin. N. Am. 37, 437–455 (2008) O. Makay, O. Unalp, G. Icoz, M. Akyildiz, E. Yetkin, Completion thyroidectomy for thyroid cancer. Acta Chir. Belg. 106, 528–531 (2006) M.R. Pelizzo, B. Franzato, A. Toniato, A. Piotto, P. Bernante, C. Bernardi, La complicanza emorragica in chirurgia tiroidea. Chirurgia 7, 165–167 (1994) O.H. Beahrs, D.J. Vandertholl, Complications of secondary thyroidectomy. Surg. Gynecol. Obstet. 117, 535–539 (1963) Y. Giles, H. Boztepe, T. Terzioglu, S. Tezelman, The advantage of total thyroidectomy to avoid reoperation for incidental thyroid cancer in multinodular goiter. Arch. Surg. 139, 179–182 (2004) M.R. Pelizzo, P. Bernante, A. Toniato, A. Fassina, Frequency of thyroid carcinoma in a recent series of 539 consecutive thyroidectomies for multinodular goiter. Tumori 83, 653–655 (1997) D. Costamagna, L. Pagano, M. Caputo, M. Leutner, F. Mercalli, A. Alonzo, Incidental cancer in patients surgically treated for benign thyroid disease. Our experience at a single institution. G. Chir. 34, 21–26 (2013) J.J. Smith, X. Chen, D.F. Schneider, J.T. Broome, R.S. Sippel, H. Chen, C.C. Solorzano, Cancer after thyroidectomy: a multi-institutional experience with 1,523 patients. J. Am. Coll. Surg. 216, 577–579 (2013) M.R. Pelizzo, A. Toniato, A. Piotto, P. Bernante, C. Pagetta, C. Bernardi, Prevenzione e trattamento delle complicanze intra- e post-operatorie in chirurgia tiroidea. Ann. Ital. Chir. 3, 273–276 (2001) L. Rosato, N. Avenia, P. Bernante, M. De Palma, G. Gulino, P.G. Nasi, M.R. Pelizzo, L. Pezzullo, Complications of thyroid surgery: analysis of a multicentric study on 14,934 patients operated on in Italy over 5 years. World J. Surg. 28, 271–276 (2004) G. Vasica, C.J. O’Neill, S.B. Sidhu, M.S. Sywak, T.S. Reeve, L.W. Delbridge, Reoperative surgery for bilateral multinodular goitre in the era of total thyroidectomy. Br. J. Surg. 99, 688–692 (2012) S.J. Bonnema, S. Fast, L. Hegedüs, Non-surgical approach to the benign nodular goiter: new opportunities by recombinant human TSH-stimulated 131I-therapy. Endocrine 40, 344–353 (2011) M. Giusti, V. Corsi, L. Mortasa, M. Caputo, E. Monti, M. Schiavo, M.C. Bagnara, F. Minuto, M. Bagnasco, Long-term outcome after radioiodine therapy with adjuvant rhTSH treatment: comparison between patients with non-toxic and pre-toxic large multinodular goitre. Endocrine 45, 221–229 (2014). doi:10.1007/s12020-013-9959-1